Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 4
2009 3
2010 3
2011 1
2019 2
2020 4
2021 10
2022 7
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review.
Filippi M, Preziosa P, Barkhof F, Chard DT, De Stefano N, Fox RJ, Gasperini C, Kappos L, Montalban X, Moraal B, Reich DS, Rovira À, Toosy AT, Traboulsee A, Weinshenker BG, Zeydan B, Banwell BL, Rocca MA. Filippi M, et al. Among authors: moraal b. JAMA Neurol. 2021 Mar 1;78(3):351-364. doi: 10.1001/jamaneurol.2020.4689. JAMA Neurol. 2021. PMID: 33315071 Review.
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.
van Lierop ZY, Toorop AA, van Ballegoij WJ, Olde Dubbelink TB, Strijbis EM, de Jong BA, van Oosten BW, Moraal B, Teunissen CE, Uitdehaag BM, Killestein J, Kempen ZLV. van Lierop ZY, et al. Among authors: moraal b. Mult Scler. 2022 Jun;28(7):1121-1125. doi: 10.1177/13524585211028833. Epub 2021 Jul 9. Mult Scler. 2022. PMID: 34240631 Free PMC article.
Non-invasively measured brain activity and radiological progression in diffuse glioma.
Numan T, Kulik SD, Moraal B, Reijneveld JC, Stam CJ, de Witt Hamer PC, Derks J, Bruynzeel AME, van Linde ME, Wesseling P, Kouwenhoven MCM, Klein M, Würdinger T, Barkhof F, Geurts JJG, Hillebrand A, Douw L. Numan T, et al. Among authors: moraal b. Sci Rep. 2021 Sep 23;11(1):18990. doi: 10.1038/s41598-021-97818-y. Sci Rep. 2021. PMID: 34556701 Free PMC article.
Project Y: The search for clues explaining phenotype variability in MS.
Loonstra FC, De Ruiter LRJ, Doesburg D, Lam KH, Van Lierop ZYGJ, Moraal B, Strijbis EMM, Killestein J, Uitdehaag BMJ. Loonstra FC, et al. Among authors: moraal b. Mult Scler Relat Disord. 2022 Jan;57:103337. doi: 10.1016/j.msard.2021.103337. Epub 2021 Oct 16. Mult Scler Relat Disord. 2022. PMID: 35158448 Free article.
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients.
van Lierop Z, Toorop AA, Coerver E, Willemse E, Strijbis E, Kalkers NF, Moraal B, Barkhof F, Teunissen CE, Killestein J, van Kempen Z. van Lierop Z, et al. Among authors: moraal b. Mult Scler J Exp Transl Clin. 2021 Jun 1;7(2):20552173211013831. doi: 10.1177/20552173211013831. eCollection 2021 Apr-Jun. Mult Scler J Exp Transl Clin. 2021. PMID: 34123391 Free PMC article.
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.
van Lierop ZY, Noteboom S, Steenwijk MD, van Dam M, Toorop AA, van Kempen ZL, Moraal B, Barkhof F, Uitdehaag BM, Schoonheim MM, Teunissen CE, Killestein J. van Lierop ZY, et al. Among authors: moraal b. Mult Scler. 2022 Dec;28(14):2231-2242. doi: 10.1177/13524585221118676. Epub 2022 Sep 3. Mult Scler. 2022. PMID: 36062492 Free PMC article.
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.
van Lierop ZY, Wieske L, Koel-Simmelink MJ, Chatterjee M, Dekker I, Leurs CE, Willemse EA, Moraal B, Barkhof F, Eftimov F, Uitdehaag BM, Killestein J, Teunissen CE. van Lierop ZY, et al. Among authors: moraal b. Mult Scler. 2022 Jan;28(1):102-110. doi: 10.1177/13524585211010097. Epub 2021 Apr 23. Mult Scler. 2022. PMID: 33890520 Free PMC article.
Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma.
Sol N, In 't Veld SGJG, Vancura A, Tjerkstra M, Leurs C, Rustenburg F, Schellen P, Verschueren H, Post E, Zwaan K, Ramaker J, Wedekind LE, Tannous J, Ylstra B, Killestein J, Mateen F, Idema S, de Witt Hamer PC, Navis AC, Leenders WPJ, Hoeben A, Moraal B, Noske DP, Vandertop WP, Nilsson RJA, Tannous BA, Wesseling P, Reijneveld JC, Best MG, Wurdinger T. Sol N, et al. Among authors: moraal b. Cell Rep Med. 2020 Oct 20;1(7):100101. doi: 10.1016/j.xcrm.2020.100101. Cell Rep Med. 2020. PMID: 33103128 Free PMC article.
31 results